Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
Influenza
ACIP: Updated Vaccine Guidance for the 2022-2023 Influenza Season
In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.
Xofluza Approved to Treat, Prevent Influenza in Pediatric Patients
The expanded approval was based on data from two phase 3 studies, miniSTONE-2 and BLOCKSTONE.
Flucelvax Quadrivalent Approval Expanded to Include Younger Patients
The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.
FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV
The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.
ACIP: 2022 Adult Immunization Schedule Updates
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
Does Heterologous COVID-19 Vaccination Protect Against Seasonal Coronaviruses?
Researchers conducted a study to determine whether homologous COVID-19 vaccination increases in vitro neutralizing activity against seasonal human coronaviruses.
Influenza Vaccination Cuts Risk of Critical Illness in Children
During a season predominated by 2 vaccine-mismatched viruses, vaccination was estimated to reduce the risk of life-threatening influenza illness by 75%.
N95 Respirators vs Surgical Masks for Protection Against Viral Respiratory Illnesses
Researchers conducted a meta-analysis to determine the effectiveness of N95 respirators vs surgical masks in protecting against viral respiratory illness transmission.
Prevnar 20 Coadministered With Flu Vaccine Immunogenic, Safe in Older Adults
The randomized, double-blind trial enrolled a total of 1796 participants, of which 1727 completed the study.
- Loading...
Loading...
Loading... 
Loading...